Epigral Ltd. Total Liabilities

Latest as of June 2026: Rs-22.21 Billion INR ≈ $-240.24 Million USD

Epigral Ltd. total liabilities. Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has total liabilities worth Rs-22.21 Billion INR (≈ $-240.24 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Epigral Ltd. liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Epigral Ltd. (2015–2026)

Total liabilities of Epigral Ltd. from 2015 to 2026. This chart illustrates how Epigral Ltd.'s total liabilities have evolved over time, based on quarterly financial data.

Epigral Ltd. Competitors by Total Liabilities

The table below lists competitors of Epigral Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Hi-Road Food Technology Co. Ltd. SHE:300915	China	CN¥241.20 Million
Compagnie du Bois Sauvage SA BR:COMB	Belgium	€291.85 Million
Albaraka Turk Katilim Bankasi AS IS:ALBRK	Turkey	TL397.50 Billion
Electrosteel Castings Limited NSE:ELECTCAST	India	Rs40.16 Billion
Beijing Shengtong Printing Co Ltd SHE:002599	China	CN¥870.12 Million
Desktop - Sigmanet Comunicação Multimídia S.A. SA:DESK3	Brazil	R$2.45 Billion
Shenzhen Xfh Technology Co Ltd SHE:300890	China	CN¥2.99 Billion
Beijing Jingyeda Technology Co Ltd SHE:003005	China	CN¥293.89 Million

Liability Composition Analysis (2015–2026)

This chart breaks down Epigral Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see EPIGRAL current and non-current assets.

Liquidity & Leverage Metrics

Epigral Ltd. Total Liabilities Ratios Explained

Epigral Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epigral Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epigral Ltd. (2015–2026)

The table below shows the annual total liabilities of Epigral Ltd. from 2015 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs12.84 Billion ≈ $138.85 Million	+2.88%
2025-03-31	Rs12.48 Billion ≈ $134.96 Million	-18.98%
2024-03-31	Rs15.40 Billion ≈ $166.57 Million	+12.99%
2023-03-31	Rs13.63 Billion ≈ $147.42 Million	-2.47%
2022-03-31	Rs13.98 Billion ≈ $151.16 Million	+82.81%
2021-03-31	Rs7.65 Billion ≈ $82.69 Million	+10.81%
2020-03-31	Rs6.90 Billion ≈ $74.62 Million	+25.12%
2019-03-31	Rs5.51 Billion ≈ $59.64 Million	+259.21%
2018-03-31	Rs1.54 Billion ≈ $16.60 Million	-7.43%
2017-03-31	Rs1.66 Billion ≈ $17.93 Million	-32.24%
2016-03-31	Rs2.45 Billion ≈ $26.47 Million	-22.05%
2015-03-31	Rs3.14 Billion ≈ $33.96 Million	--

About Epigral Ltd.

NSE:EPIGRAL India Chemicals

Market Cap

$443.93 Million

Rs41.05 Billion INR

Market Cap Rank

#12562 Global

#625 in India

Share Price

Rs951.50

Change (1 day)

+8.81%

52-Week Range

Rs810.45 - Rs1682.00

All Time High

Rs2344.35